Anti-FZD8/ FZ-8/ hFZ8 monoclonal antibody

Anti-FZD8/ FZ-8/ hFZ8 antibody for FACS & in-vivo assay

Target products collectionGo to FZD8/FZD8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0466-Ab-1/ GM-Tg-hg-MP0466-Ab-2Anti-Human FZD8 monoclonal antibodyHuman
GM-Tg-rg-MP0466-Ab-1/ GM-Tg-rg-MP0466-Ab-2Anti-Rat FZD8 monoclonal antibodyRat
GM-Tg-mg-MP0466-Ab-1/ GM-Tg-mg-MP0466-Ab-2Anti-Mouse FZD8 monoclonal antibodyMouse
GM-Tg-cynog-MP0466-Ab-1/ GM-Tg-cynog-MP0466-Ab-2Anti-Cynomolgus/ Rhesus macaque FZD8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0466-Ab-1/ GM-Tg-felg-MP0466-Ab-2Anti-Feline FZD8 monoclonal antibodyFeline
GM-Tg-cang-MP0466-Ab-1/ GM-Tg-cang-MP0466-Ab-2Anti-Canine FZD8 monoclonal antibodyCanine
GM-Tg-bovg-MP0466-Ab-1/ GM-Tg-bovg-MP0466-Ab-2Anti-Bovine FZD8 monoclonal antibodyBovine
GM-Tg-equg-MP0466-Ab-1/ GM-Tg-equg-MP0466-Ab-2Anti-Equine FZD8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0466-Ab-1/ GM-Tg-hg-MP0466-Ab-2; GM-Tg-rg-MP0466-Ab-1/ GM-Tg-rg-MP0466-Ab-2;
GM-Tg-mg-MP0466-Ab-1/ GM-Tg-mg-MP0466-Ab-2; GM-Tg-cynog-MP0466-Ab-1/ GM-Tg-cynog-MP0466-Ab-2;
GM-Tg-felg-MP0466-Ab-1/ GM-Tg-felg-MP0466-Ab-2; GM-Tg-cang-MP0466-Ab-1/ GM-Tg-cang-MP0466-Ab-2;
GM-Tg-bovg-MP0466-Ab-1/ GM-Tg-bovg-MP0466-Ab-2; GM-Tg-equg-MP0466-Ab-1/ GM-Tg-equg-MP0466-Ab-2
Products NameAnti-FZD8 monoclonal antibody
Formatmab
Target NameFZD8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FZD8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species FZD8/ FZ-8/ hFZ8 VLP (virus-like particle) (Products Developing)
    CytokineGM-Tg-g-MP0466-Ag-1frizzled class receptor 8 (FZD8) protein


    Target information

    Target IDGM-MP0466
    Target NameFZD8
    Gene ID8325,14370,364754,708368,487073,101101229,616913,111771171
    Gene Symbol and SynonymsFZ-8,Fz8,FZD8,hFZ8
    Uniprot AccessionQ9H461,Q498S8
    Uniprot Entry NameFZD8_HUMAN,FZD8_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryCytokine Target
    DiseaseN/A
    Gene EnsemblENSG00000177283
    Target ClassificationN/A

    The target: FZD8, gene name: FZD8, also named as FZ-8, hFZ8. This intronless gene is a member of the frizzled gene family. Members of this family encode seven-transmembrane domain proteins that are receptors for the Wingless type MMTV integration site family of signaling proteins. Most frizzled receptors are coupled to the beta-catenin canonical signaling pathway. This gene is highly expressed in two human cancer cell lines, indicating that it may play a role in several types of cancer. The crystal structure of the extracellular cysteine-rich domain of a similar mouse protein has been determined. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.